Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1987 Aug;56(2):103–109. doi: 10.1038/bjc.1987.165

Chemosensitization by misonidazole in CCNU-treated spheroids and tumours.

R E Durand 1, D J Chaplin 1
PMCID: PMC2002149  PMID: 3663461

Abstract

Misonidazole has been demonstrated to enhance the cytotoxicity of several common antineoplastic drugs in vitro and in vivo, and its mechanism of action as a chemosensitizer, though still unknown, is thought to be dependent upon hypoxia. We have used fluorescence-activated cell sorting to evaluate chemopotentiation by misonidazole as a function of cell position in V79 spheroids and KHT tumours. CCNU toxicity was enhanced in all cell subpopulations of both tumours and spheroids, with greater consistency than might be predicted on the basis of the known variations in oxygen tension. Further, both misonidazole and CCNU as single agents were preferentially toxic in the less well oxygenated regions of each system, arguing that differential toxicity cannot be implicated in the chemopotentiation observed. In fact, increased treatment toxicity did not necessarily lead to increased chemopotentiation, nor was potentiation directly related to the metabolism/binding of the misonidazole. Chemopotentiation in multicell systems thus appears to be a complex, multi-factorial process.

Full text

PDF
103

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berenbaum M. C. Criteria for analyzing interactions between biologically active agents. Adv Cancer Res. 1981;35:269–335. doi: 10.1016/s0065-230x(08)60912-4. [DOI] [PubMed] [Google Scholar]
  2. Brown J. M. The mechanisms of cytotoxicity and chemosensitization by misonidazole and other nitroimidazoles. Int J Radiat Oncol Biol Phys. 1982 Mar-Apr;8(3-4):675–682. doi: 10.1016/0360-3016(82)90711-8. [DOI] [PubMed] [Google Scholar]
  3. Chaplin D. J., Durand R. E., Olive P. L. Acute hypoxia in tumors: implications for modifiers of radiation effects. Int J Radiat Oncol Biol Phys. 1986 Aug;12(8):1279–1282. doi: 10.1016/0360-3016(86)90153-7. [DOI] [PubMed] [Google Scholar]
  4. Chaplin D. J., Durand R. E., Olive P. L. Cell selection from a murine tumour using the fluorescent probe Hoechst 33342. Br J Cancer. 1985 Apr;51(4):569–572. doi: 10.1038/bjc.1985.79. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chaplin D. J., Durand R. E., Stratford I. J., Jenkins T. C. The radiosensitizing and toxic effects of RSU-1069 on hypoxic cells in a murine tumor. Int J Radiat Oncol Biol Phys. 1986 Jul;12(7):1091–1095. doi: 10.1016/0360-3016(86)90233-6. [DOI] [PubMed] [Google Scholar]
  6. Chapman J. D., Franko A. J., Sharplin J. A marker for hypoxic cells in tumours with potential clinical applicability. Br J Cancer. 1981 Apr;43(4):546–550. doi: 10.1038/bjc.1981.79. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chou T. C., Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul. 1984;22:27–55. doi: 10.1016/0065-2571(84)90007-4. [DOI] [PubMed] [Google Scholar]
  8. Clement J. J., Gorman M. S., Wodinsky I., Catane R., Johnson R. K. Enhancement of antitumor activity of alkylating agents by the radiation sensitizer misonidazole. Cancer Res. 1980 Nov;40(11):4165–4172. [PubMed] [Google Scholar]
  9. Courtenay V. D. A soft agar colony assay for Lewis lung tumour and B16 melanoma taken directly from the mouse. Br J Cancer. 1976 Jul;34(1):39–45. doi: 10.1038/bjc.1976.119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Deen D. F., Hoshino T., Williams M. E., Muraoka I., Knebel K. D., Barker M. Development of a 9L rat brain tumor cell multicellular spheroid system and its response to 1,3-bis(2-chloroethyl)-1-nitrosourea and radiation. J Natl Cancer Inst. 1980 Jun;64(6):1373–1382. doi: 10.1093/jnci/64.6.1373. [DOI] [PubMed] [Google Scholar]
  11. Durand R. E., Olive P. L. Potentiation of CCNU toxicity by AF-2 in V79 spheroids: implications for mechanisms of chemosensitization. Int J Radiat Oncol Biol Phys. 1986 Aug;12(8):1375–1378. doi: 10.1016/0360-3016(86)90175-6. [DOI] [PubMed] [Google Scholar]
  12. Durand R. E. Oxygen enhancement ratio in V79 spheroids. Radiat Res. 1983 Nov;96(2):322–334. [PubMed] [Google Scholar]
  13. Durand R. E. Use of Hoechst 33342 for cell selection from multicell systems. J Histochem Cytochem. 1982 Feb;30(2):117–122. doi: 10.1177/30.2.6174559. [DOI] [PubMed] [Google Scholar]
  14. Durand R. E. Use of a cell sorter for assays of cell clonogenicity. Cancer Res. 1986 Jun;46(6):2775–2778. [PubMed] [Google Scholar]
  15. Hall E. J., Roizin-Towle L. Hypoxic sensitizers: radiobiological studies at the cellular level. Radiology. 1975 Nov;117(2):453–457. doi: 10.1148/117.2.453. [DOI] [PubMed] [Google Scholar]
  16. Kelly J. P., Hannam T. W., Giles G. R. The cytocidal action of metronidazole in combination with other antineoplastic agents. Cancer Treat Rev. 1979 Jun;6 (Suppl):53–61. doi: 10.1016/s0305-7372(79)80013-4. [DOI] [PubMed] [Google Scholar]
  17. Kwok T. T., Twentyman P. R. The relationship between tumour geometry and the response of tumour cells to cytotoxic drugs--an in vitro study using EMT6 multicellular spheroids. Int J Cancer. 1985 May 15;35(5):675–682. doi: 10.1002/ijc.2910350517. [DOI] [PubMed] [Google Scholar]
  18. Lee F. Y., Workman P. Interaction of nitroimidazole sensitizers with drug metabolizing enzymes--spectral and kinetic studies. Int J Radiat Oncol Biol Phys. 1986 Aug;12(8):1383–1387. doi: 10.1016/0360-3016(86)90177-x. [DOI] [PubMed] [Google Scholar]
  19. Moore B. A., Palcic B., Skarsgard L. D. Radiosensitizing and toxic effects on the 2-nitroimidazole Ro-07-0582 in hypoxic mammation cells. Radiat Res. 1976 Sep;67(3):459–473. [PubMed] [Google Scholar]
  20. Moulder J. E., Rockwell S. Hypoxic fractions of solid tumors: experimental techniques, methods of analysis, and a survey of existing data. Int J Radiat Oncol Biol Phys. 1984 May;10(5):695–712. doi: 10.1016/0360-3016(84)90301-8. [DOI] [PubMed] [Google Scholar]
  21. Mulcahy R. T. Cross-link formation and chemopotentiation of EMT-6/Ro cells exposed to MISO after CCNU treatment in vitro. Int J Radiat Oncol Biol Phys. 1986 Aug;12(8):1389–1392. doi: 10.1016/0360-3016(86)90178-1. [DOI] [PubMed] [Google Scholar]
  22. Mulcahy R. T. Effect of oxygen on misonidazole chemosensitization and cytotoxicity in vitro. Cancer Res. 1984 Oct;44(10):4409–4413. [PubMed] [Google Scholar]
  23. Olive P. L., Chaplin D. J., Durand R. E. Pharmacokinetics, binding and distribution of Hoechst 33342 in spheroids and murine tumours. Br J Cancer. 1985 Nov;52(5):739–746. doi: 10.1038/bjc.1985.252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Olive P. L., Durand R. E. Fluorescent nitroheterocycles for identifying hypoxic cells. Cancer Res. 1983 Jul;43(7):3276–3280. [PubMed] [Google Scholar]
  25. Olive P. L., McCalla D. R. Damage to mammalian cell DNA by nitrofurans. Cancer Res. 1975 Mar;35(3):781–784. [PubMed] [Google Scholar]
  26. Siemann D. W. Modification of chemotherapy by nitroimidazoles. Int J Radiat Oncol Biol Phys. 1984 Sep;10(9):1585–1594. doi: 10.1016/0360-3016(84)90508-x. [DOI] [PubMed] [Google Scholar]
  27. Sutherland R. M., Durand R. E. Radiation response of multicell spheroids--an in vitro tumour model. Curr Top Radiat Res Q. 1976 Jan;11(1):87–139. [PubMed] [Google Scholar]
  28. Taylor Y. C., Bump E. A., Brown J. M. Studies on the mechanism of chemosensitization by misonidazole in vitro. Int J Radiat Oncol Biol Phys. 1982 Mar-Apr;8(3-4):705–708. doi: 10.1016/0360-3016(82)90717-9. [DOI] [PubMed] [Google Scholar]
  29. Urtasun R. C., Tanasichuk H., Fulton D., Raleigh J., Rabin H. R., Turner R., Koziol D., Agboola O. Pharmacokinetic interaction of BCNU and misonidazole in humans. Int J Radiat Oncol Biol Phys. 1982 Mar-Apr;8(3-4):381–386. doi: 10.1016/0360-3016(82)90644-7. [DOI] [PubMed] [Google Scholar]
  30. Wheeler K. T., Wallen C. A., Wolf K. L., Siemann D. W. Hypoxic cells and in situ chemopotentiation of the nitrosoureas by misonidazole. Br J Cancer. 1984 Jun;49(6):787–793. doi: 10.1038/bjc.1984.122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Workman P., Twentyman P. R., Lee F. Y., Walton M. I. Drug metabolism and chemosensitization. Nitroimidazoles as inhibitors of drug metabolism. Biochem Pharmacol. 1983 Mar 1;32(5):857–864. doi: 10.1016/0006-2952(83)90588-9. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES